Stock market Updates | Sun Pharma Advanced Research Company Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY18812.50  +54.15 (+0.29%)
SENSEX63284.19  +184.54 (+0.29%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileSmart Quotes

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : MiscellaneousHouse : Sun Pharma
BSE256.005.05 (+2.01 %)
PREV CLOSE (Rs.) 250.95
OPEN PRICE (Rs.) 248.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 44854
TODAY'S LOW / HIGH (Rs.)248.15 259.75
52 WK LOW / HIGH (Rs.)172.45 348.75
NSE256.105.4 (+2.15 %)
PREV CLOSE( Rs. ) 250.70
OPEN PRICE (Rs.) 250.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 256.10 (196)
VOLUME 703914
TODAY'S LOW / HIGH(Rs.) 248.60 259.70
52 WK LOW / HIGH (Rs.)170.45 349

Smart Quotes

BSE NSE
1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
114.61
Dividend Yield(%)
0.00
TTM EPS (Rs.)
-8.63
P/E Ratio
0.00
Book Value (Rs.)
-12.84
Face Value (Rs.)
1
MCap (Rs. in Mn)
70484.34
Price/Earning (TTM)
-31.07
Price/Sales (TTM)
47.82
Price/Book (MRQ)
-19.94
PAT Margin (%)
-148.19
ROCE (%)
-225.57
company info
Incorporation Year : 31-03 2006

Management Info :

Dilip S Shanghvi - Chairman - Managing Director

Registered Office :

Address : Plot No.5 & 6/1, Savli G. I. D. C. Estate,Savli - Vadodara Highway,Manjusar ,
Vadodara,
Gujarat-391775

Phone : 0265- 2330815

Website : www.sparc.life

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
News
18Nov SPARC jumps on getting nod for SEZABY
Sun Pharma Advanced Research Company is currently trading at Rs. 242.25,..
18Nov Sun Pharma Advanced Research Company i
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
18Nov SPARC, Sun Pharma get nod for SEZABY f
Sun Pharma Advanced Research Company (SPARC) and Sun Pharmaceutical Indu..
more
Financials
QTR Sep 22 ANNUAL 22
Net Profit-684-2034
Gross Profit -684 -2034
Operating Profit -625.4 -1799.1
Net Sales 315.4 1372.5
more
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
WH Brady (BSE)
Rwadiwala-peer-arrow  268.35 (19.99%)
M.Cap (Rs. in Cr)68.43
TeamLease Services (BSE)
Rwadiwala-peer-arrow  2517.10 (1.20%)
M.Cap (Rs. in Cr)4303.43
Quint Digital Media (BSE)
Rwadiwala-peer-arrow  345.55 (8.95%)
M.Cap (Rs. in Cr)759.17
Evans Electric (BSE)
Rwadiwala-peer-arrow  294.15 (5.00%)
M.Cap (Rs. in Cr)40.36
Shareholding Pattern
PROMOTERS
69.09%
NON-INSTITUTION
27.77%
MUTUAL FUNDS/UTI
0.24%
FI/BANKS/INSURANCE
0%
GOVERNMENT
0%
FII
0%
more
Mf Holdings
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
ATTENTION INVESTORS Advisory for Investors Advisory - KYC Compliance
  • 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
  • 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • 3. Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  |  Advisory For Investors  |  MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  Investor Charter   |  Investor Complaints   | To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.